Fitscript
Fitscript: A digital therapeutic platform offering personalized fitness prescriptions for diabetes management.
Founded
2012Fitscript: A digital therapeutic platform offering personalized fitness prescriptions for diabetes management.
Founded with the mission to revolutionize diabetes management, Fitscript offers a digital therapeutic platform known as GlucoseZone. The company's core vision is to empower individuals with diabetes through personalized fitness prescriptions tailored to their real-time glucose levels, specific diabetes conditions, and fitness goals. Fitscript provides specialized exercise guidance for both type 1 and type 2 diabetes patients, aiming to stabilize glucose levels and promote weight loss, respectively. Their services are accessible via a comprehensive app suite, making diabetes management more effective and convenient.
Notable figures associated with Fitscript include experts in digital health and diabetes care, though specific names are not provided. The company has garnered attention for its innovative approach to integrating fitness with medical data, significantly impacting the lives of those managing diabetes. Fitscript's achievements include developing a user-friendly platform that adapts to individual health metrics, thus improving adherence to exercise regimens and overall health outcomes. Their impact is reflected in the enhanced quality of life for users who benefit from tailored fitness programs designed to meet their unique health needs.
Companies similar to Fitscript include Databetes, True Adherence, Prescribe FIT and One Drop.
Fitscript was founded in 2012.
Fitscript's headquarters is located in New Haven, CT, US.
Fitscript's most recent funding round was for $1.5M (USD) in May 2018.
As of May 16, 2018, Fitscript has raised a total of $6M (USD).
Fitscript has 11 employees as of Feb 5, 2024.
prescribefit.com
